Seek Returns

Qiagen (QGEN) Stock Analysis

This is a peer-relative look at Qiagen (QGEN): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Pharmaceuticals, Biotechnology & Life Sciences peers, so every number reads in context rather than in isolation.

Company Profile

Company profile fields for Qiagen (QGEN)
Profile ItemQGEN
NameQiagen N.V.
Country/RegionNetherlands
GICS SectorHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & Services
Market Capitalization10.39 billion USD
CurrencyUSD
ExchangeNYSE
Listing DateJune 28, 1996
Security TypeCommon Stock

Price Performance

Cumulative Growth

QGEN
GSPC
Loading price history…
Qiagen (QGEN) vs. S&P 500 (GSPC): Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Qiagen (QGEN) and S&P 500 (GSPC). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Qiagen (QGEN) and S&P 500 (GSPC). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
Total Return (1Y)17.09%24.62%
Total Return (3Y, Annualized)10.44%20.37%
Total Return (5Y, Annualized)-0.72%-4.02%

Risk Profile

Drawdown History

QGEN
GSPC
Loading price history…
Qiagen (QGEN) vs. S&P 500 (GSPC): Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Qiagen (QGEN) and S&P 500 (GSPC). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
Volatility (1Y, Annualized)35.52%66.36%
Beta (5Y)0.560.93
Max Drawdown (5Y)-41.97%-80.19%

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
Each dot is a stock plotted by 1-year volatility (risk) and 1-year return. QGEN is highlighted; the dashed line is the Capital Allocation Line from the risk-free rate through the industry median — dots above it are stronger on a risk-adjusted basis.

Risk-Adjusted Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
Sharpe Ratio (1Y)0.360.36
Sortino Ratio (1Y)0.600.58

Profitability

ROE (TTM)

Qiagen (QGEN) posts ROE of 10.81%, in the upper peer quartile. That suggests the company earns more from each dollar of shareholders’ equity than most industry peers, a useful capital-efficiency signal.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

10.81%

Group distribution
Max
109.18%
QGEN
10.81%
Q3
6.23%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Largest peers
LLY
86.02%
NVS
24.33%
AZN
22.57%
JNJ
20.02%
QGEN
10.81%
MRK
5.06%
ABBV
--
Loading chart…
Where Qiagen (QGEN) stands on ROE within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Net Margin (TTM)

Qiagen (QGEN) keeps 18.20% of revenue as net profit on net margin, above the industry benchmark range. That is unusually strong bottom-line conversion, though tax effects, asset sales, or other one-off gains should be checked before treating it as durable.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.20%

Group distribution
QGEN
18.20%
Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Largest peers
LLY
31.90%
QGEN
18.20%
AZN
17.68%
NVS
17.49%
JNJ
16.20%
ABBV
15.67%
MRK
3.64%
Loading chart…
Where Qiagen (QGEN) stands on net margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Operating Margin (TTM)

Qiagen (QGEN) turns 27.75% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.75%

Group distribution
Max
83.12%
QGEN
27.75%
Q3
14.77%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Largest peers
LLY
53.66%
ABBV
39.59%
MRK
35.22%
NVS
34.27%
AZN
29.57%
QGEN
27.75%
JNJ
25.74%
Loading chart…
Where Qiagen (QGEN) stands on operating margin within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Profitability Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
ROE (TTM)10.81%-26.66%
ROA (TTM)5.68%-12.50%
Net Margin (TTM)18.20%0.00%
Operating Margin (TTM)27.75%0.00%
Gross Margin (TTM)67.06%37.87%

Growth

Revenue Growth

Qiagen (QGEN) grew revenue 5.65%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.

Loading chart…
Qiagen (QGEN): Revenue Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

EPS Growth

Qiagen (QGEN) grew earnings per share 409.76%, above the industry benchmark range. Profits are compounding faster than at any typical peer, though a depressed base year can inflate the percentage, so the level of earnings matters alongside the rate.

Loading chart…
Qiagen (QGEN): EPS Growth across different time periods, set against Pharmaceuticals, Biotechnology & Life Sciences industry-group medians.

Growth Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
Revenue Growth (YoY)5.65%11.45%
Revenue Growth (3Y CAGR)-0.81%9.94%
EPS Growth (YoY)409.76%4.28%
EPS Growth (3Y CAGR)-0.19%4.17%

Financial Strength

Current Ratio (MRQ)

Qiagen (QGEN) has current ratio of 2.63, in the healthier middle range for its industry. The short-term asset cushion looks balanced relative to peers rather than stretched thin.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.63

Group distribution
Max
25.13
Q3
12.13
Median
5.52
QGEN
2.63
Q1
2.47
Min
0.10
Largest peers
QGEN
2.63
LLY
1.39
MRK
1.35
JNJ
1.02
AZN
1.01
NVS
0.88
ABBV
0.87
Loading chart…
Where Qiagen (QGEN) stands on current ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Debt / Equity (MRQ)

Qiagen (QGEN) has debt-to-equity ratio of 0.47, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.47

Group distribution
Max
1.42
Q3
0.65
QGEN
0.47
Median
0.15
Q1
0.02
Min
0.00
Largest peers
NVS
1.29
LLY
1.23
MRK
1.20
AZN
0.66
JNJ
0.55
QGEN
0.47
ABBV
--
Loading chart…
Where Qiagen (QGEN) stands on debt-to-equity ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Financial Strength Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
Current Ratio (MRQ)2.635.52
Debt / Equity (MRQ)0.470.15
Net Debt / EBITDA1.081.08

Dividends

Dividend Yield (TTM)

Qiagen (QGEN) has dividend yield of 0.71%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.71%

Group distribution
QGEN
0.71%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
NVS
2.88%
ABBV
2.40%
MRK
2.29%
JNJ
1.94%
AZN
1.73%
QGEN
0.71%
LLY
0.49%
Loading chart…
Where Qiagen (QGEN) stands on dividend yield within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Payout Ratio (TTM)

Qiagen (QGEN) has payout ratio of 18.21%, above the peer distribution for its industry. The dividend consumes more reported earnings than peers normally do, leaving unusually thin earnings cover.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

18.21%

Group distribution
QGEN
18.21%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Largest peers
MRK
343.43%
ABBV
117.35%
NVS
90.46%
JNJ
80.12%
AZN
45.38%
LLY
21.71%
QGEN
18.21%
Loading chart…
Where Qiagen (QGEN) stands on payout ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Dividend Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
Dividend Yield (TTM)0.71%0.00%
Dividend Payout Ratio (TTM)18.21%0.00%

Valuation

P/E Ratio (TTM)

Qiagen (QGEN) trades at P/E ratio of 27.21, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.21

Group distribution
Max
85.34
Q3
43.46
QGEN
27.21
Median
26.69
Q1
13.30
Min
0.07
Largest peers
MRK
148.21
ABBV
50.05
LLY
43.95
JNJ
41.92
NVS
31.02
QGEN
27.21
AZN
26.37
Loading chart…
Where Qiagen (QGEN) stands on P/E ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/S Ratio (TTM)

Qiagen (QGEN) trades at 4.91 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

4.91

Group distribution
Max
58.18
Q3
25.77
Median
7.30
QGEN
4.91
Q1
3.01
Min
0.01
Largest peers
LLY
13.95
ABBV
7.80
JNJ
6.69
MRK
5.37
NVS
5.35
QGEN
4.91
AZN
4.63
Loading chart…
Where Qiagen (QGEN) stands on P/S ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

P/B Ratio (MRQ)

Qiagen (QGEN) trades at 2.99 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.

QGEN

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.99

Group distribution
Max
13.53
Q3
6.54
Median
3.25
QGEN
2.99
Q1
1.69
Min
-5.59
Largest peers
LLY
29.96
NVS
8.25
JNJ
8.16
MRK
8.06
AZN
5.59
QGEN
2.99
ABBV
-112.34
Loading chart…
Where Qiagen (QGEN) stands on P/B ratio within its Pharmaceuticals, Biotechnology & Life Sciences peer group — the box is the group’s distribution and the dots its largest members.

Valuation Metrics

Qiagen (QGEN) metric values compared with Pharmaceuticals, Biotechnology & Life Sciences industry-group medians
MetricCurrent stock: QGENIndustry group median
P/E Ratio (TTM)27.2126.69
P/S Ratio (TTM)4.917.30
P/B Ratio (MRQ)2.993.25
Free Cash Flow Yield (TTM)3.62%-1.66%